Vasotocin analogues with selective natriuretic, kaliuretic and antidiuretic effects in rats

Regulatory Peptides

Volumn 185, Issue , 2013, Pages 57-64

  Kutina, Anna V ^a   Marina, Anna S ^a   Shakhmatova, Elena I ^a   Natochin, Yury V ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Antidiuresis; Kaliuresis; Natriuresis; Vasopressin; Vasotocin analogues

Indexed keywords

ARGIPRESTOCIN; CYCLIC AMP; CYCLIC GMP; DESMOPRESSIN; NONAPEPTIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1A LIKE RECEPTOR; VASOPRESSIN V1A RECEPTOR; VASOTOCIN DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ANTIDIURESIS; ARTICLE; CONTROLLED STUDY; DIURESIS; DIURETIC ACTIVITY; DRUG POTENCY; FEMALE; HORMONAL REGULATION; KALIURESIS; NONHUMAN; POTASSIUM EXCRETION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM TRANSPORT; WATER ABSORPTION; WATER TRANSPORT;

ANTIDIURESIS; DAAVT; DAVT; DDAVT; KALIURESIS; MPA(1)-ARG(4)-VASOTOCIN; MPA(1)-DARG(8)-VASOTOCIN; MPA(1)-VASOTOCIN; NATRIURESIS; VASOPRESSIN; VASOTOCIN ANALOGUES;

ANIMALS; ANTIDIURETIC AGENTS; CYCLIC AMP; CYCLIC GMP; DINOPROSTONE; FEMALE; KIDNEY; NATRIURESIS; POTASSIUM; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; SODIUM; VASOPRESSINS; VASOTOCIN; WATER;

EID: 84880713389     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.06.013     Document Type: Article

References (50)

1. Bentley P.J. Endocrines and osmoregulation. A comparative account in vertebrates 2002, Springer, Berlin, Heidelberg, New York. 2nd ed.
2. Balment R.J., Brimble M.J., Forsling M.L., Musabayane C.T. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range. J Physiol 1984, 352:517-526.
3. Forsling M.L., Judah J.M., Windle R.J. The effect of vasopressin and oxytocin on glomerular filtration rate in the conscious rat: contribution to the natriuretic response. J Endocrinol 1994, 141:59-67.
4. Nonoguchi H., Takayama M., Owada A., Ujiie K., Yamada T., Nakashima O., Sakuma Y., Koike J., Terada Y., Marumo F., Tomita K. Role of urinary arginine vasopressin in the sodium excretion in patients with chronic renal failure. Am J Med Sci 1996, 312:195-201.
5. 2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 2005, 16:1920-1928.
6. Perucca J., Bichet D.G., Bardoux P., Bouby N., Bankir L. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 2008, 19:1721-1731.
7. Knepper M.A., Kim G.H., Fernández-Llama P., Ecelbarger C.A. Regulation of thick ascending limb transport by vasopressin. J Am Soc Nephrol 1999, 10:628-634.
8. + permeabilities in toad urinary bladder: one or two solute pathways?. Am J Physiol 1985, 248:F56-F63.
9. Bens M., Chassin C., Vandewalle A. Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells. Pflugers Arch 2006, 453:133-146.
10. Blanchard A., Frank M., Wuerzner G., Peyrard S., Bankir L., Jeunemaitre X., Azizi M. Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent. Clin J Am Soc Nephrol 2011, 6:753-759.
11. + secretion. Kidney Int 2004, 66:696-704.
12. Gao T., Natochin Iu.V. Evolutionary advantage of vasopressin substitution for vasotocin in mineral metabolism of the mammals. Zh Evol Biokhim Fiziol 2004, 40:168-172.
13. Karavashkina T.A., Kutina A.V., Shakhmatova E.I., Natochin Yu.V. Mechanism of 1-deamino-arginine vasotocin induced natriuresis in rats. Gen Comp Endocrinol 2011, 170:460-467.
14. Kutina A.V., Marina A.S., Titov M.I., Natochin Yu.V. Kaliuretic nonapeptide. Dokl Biol Sci 2012, 444:147-149.
15. Natochin Y.V., Buravkova L.B., Shakhmatova E.I., Larina I.M., Kanashkina T.A., Krotov V.P., Az'muko A.A., Ovchinnikov M.V., Grigoriev A.I. The effects of synthesized analogs of vasotocin on water and ion excretion by the rat and monkey kidneys. Dokl Biol Sci 2006, 406:11-13.
16. Brod J. The Kidney 1973, Butterworth, London.
17. Manning M., Misicka A., Olma A., Bankowski K., Stoev S., Chini B., Durroux T., Mouillac B., Corbani M., Guillon G. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 2012, 24:609-628.
18. Park R.G., Congiu M., Denton D.A., McKinley M.J. Natriuresis induced by arginine vasopressin infusion in sheep. Am J Physiol 1985, 249:F799-F805.
19. Kompanowska-Jezierska E., Emmeluth C., Grove L., Christensen P., Sadowski J., Bie P. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins. Am J Physiol 1998, 274:R1619-R1625.
20. Field M.J., Stanton B.A., Giebisch G.H. Influence of ADH on renal potassium handling: a micropuncture and microperfusion study. Kidney Int 1984, 25:502-511.
21. Schlatter E. Regulation of ion channels in the cortical collecting duct. Ren Physiol Biochem 1993, 16:21-36.
22. Amorim J.B., Malnic G. V(1) receptors in luminal action of vasopressin on distal K(+) secretion. Am J Physiol Renal Physiol 2000, 278:F809-F816.
23. Walter R. Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophysial hormones by kidney preparations of various species. Biochim Biophys Acta 1976, 422:138-158.
24. Wallis M.G., Lankford M.F., Keller S.R. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am J Physiol Endocrinol Metab 2007, 293:E1092-E1102.
25. Cort J.H., Schück O., Stríbrná J., Skopková J., Jost K., Mulder J.L. Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat. Kidney Int 1975, 8:292-302.
26. Kutina A.V., Marina A.S., Eliseev I.I., Titov M.I., Natochin Y.V. Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats. J Pept Sci 2013, 19:268-276.
27. Vasopressin, eds. Gross P, Richter D, Robertson GL. John Libbey Eurotext, Paris, 1993.
28. 1a receptor agonists. Adv Exp Med Biol 2009, 611:507-508.
29. Aronson J.K. Meyler's side effects of endocrine and metabolic drugs 2009, 520-525. Elsevier Science, Amsterdam.
30. Badiu C., Coculescu M., Moller M. Arginine vasotocin mRNA revealed by in situ hybridization in bovine pineal gland cells. Cell Tissue Res 1999, 295:225-229.
31. Prechel M.M., Audhya T.K., Simmons W.H. Influence of age on August levels of pineal immunoreactive arginine vasotocin in rats. J Pineal Res 1989, 6:1-7.
32. Burgess W.J., Balment R.J., Beck J.S. Effects of luminal vasopressin on intracellular calcium in microperfused rat medullary thick ascending limb. Ren Physiol Biochem 1994, 17:1-9.
33. Grider J., Falcone J., Kilpatrick E., Ott C., Jackson B. Effect of luminal vasopressin on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol 1996, 313:115-118.
34. 2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 2007, 293:F1166-F1177.
35. Saito M., Tahara A., Sugimoto T., Abe K., Furuichi K. Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor. Eur J Pharmacol 2000, 401:289-296.
36. 2 receptors mRNA in the kidney and heart of the renin transgenic TGR(mRen2)27 and Sprague Dawley rats. J Physiol Pharmacol 2002, 53:349-357.
37. Roper J., O'Carroll A.M., Young W., Lolait S. The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress 2011, 14:98-115.
38. 1a receptor-deficient mice. Kidney Int 2009, 76:1035-1039.
39. Goncharevskaya O.A., Shakhmatova E.I., Natochin Y.V. Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists. Pflugers Arch 1995, 430:1004-1011.
40. Kutina A.V., Eliseev I.I., Titov M.I., Natochin Yu.V. Replacement of L-arginine(8) by D-arginine(8) cancels the natriuretic effect of arginine vasotocin analogs in rats. Dokl Biol Sci 2008, 422:298-300.
41. 1a type receptors and their ligands. J Biol Chem 2004, 279:54445-54453.
42. 2+. Pflugers Arch 1996, 433:109-115.
43. Dai L.J., Ritchie G., Kerstan D., Kang H.S., Cole D.E., Quamme G.A. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 2001, 81:51-84.
44. 2 receptor defective mechanism. Kidney Int 1989, 36:859-866.
45. Soares T.J., Coimbra T.M., Martins A.R., Pereira A.G., Carnio E.C., Branco L.G., Albuquerque-Araujo W.I., de Nucci G., Favaretto A.L., Gutkowska J., McCann S.M., Antunes-Rodrigues J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A 1999, 96:278-283.
46. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med 1998, 339:321-328.
47. Herbert S.C., Desir G., Giebish G., Wang W. Molecular diversity and regulation of renal potassium channels. Physiol Rev 2005, 85:319-371.
48. Maybauer M.O., Maybauer D.M., Enkhbaatar P., Traber D.L. Physiology of the vasopressin receptors. Best Pract Res Clin Anaesthesiol 2008, 22:253-263.
49. + channels in renal medullary vesicles by cAMP-dependent protein kinase. J Membr Biol 1989, 109:65-72.
50. Ecelbarger C.A., Kim G.H., Knepper M.A., Liu J., Tate M., Welling P.A., Wade J.B. Regulation of potassium channel Kir 1.1 (ROMK) abundance in the thick ascending limb of Henle's loop. J Am Soc Nephrol 2001, 12:10-18.